We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

Global Stem Cell Treatments for Cancer Market, 2021-2027

Cancer stem cells (CSCs) are responsible for carcinogenesis and tumorigenesis and are involved in drug and radiation resistance, metastasis, tumor relapse and initiation. Gen Consulting Company predicts the global stem cell treatments for cancer market will grow from USD 1,879 million in 2020 to USD 3,756 million by 2027, achieving a compound annual growth rate (CAGR) of 10.4 percent.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global stem cell treatments for cancer market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments.

The stem cell treatments for cancer market is segmented on the basis of cancer type, and region. The stem cell treatments for cancer market is segmented as below:

By cancer type:
- bone cancer
- brain cancer
- breast cancer
- colorectal cancer
- leukemia
- lung cancer
- melanoma
- prostate cancer
- others

By region:
- Asia Pacific
- Europe
- North America
- Rest of the World (RoW)

The global stem cell treatments for cancer market report offers detailed information on several market vendors, including apceth Biopharma GmbH, BioNTech SE, Celgene Corporation, ExCellThera Inc., Fluxion Biosciences, Inc., Gamida-Cell Ltd, ImmunoCellular Therapeutics, Ltd., OncoCyte Corporation, OncoMed Pharmaceuticals, Inc., Pluristem Therapeutics Inc., SELLAS Life Sciences Group, Inc., ViaCyte, Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report
- To analyze and forecast the market size of the global stem cell treatments for cancer market.
- To classify and forecast the global stem cell treatments for cancer market based on cancer type, and region.
- To identify drivers and challenges for the global stem cell treatments for cancer market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global stem cell treatments for cancer market.
- To identify and analyze the profile of leading players operating in the global stem cell treatments for cancer market.

Why Choose This Report
- Gain a reliable outlook of the global stem cell treatments for cancer market forecasts from 2021 to 2027 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.

Part 1. Introduction
1.1 Market definition
1.2 Key benefits
1.3 Market segment
Part 2. Methodology
2.1 Primary
2.2 Secondary
Part 3. Executive summary

Part 4. Market overview
4.1 Introduction
4.2 Market dynamics
4.2.1 Drivers
4.2.2 Restraints

Part 5. Global market for stem cell treatments for cancer by cancer type
5.1 Bone cancer
5.1.1 Market size and forecast
5.2 Brain cancer
5.2.1 Market size and forecast
5.3 Breast cancer
5.3.1 Market size and forecast
5.4 Colorectal cancer
5.4.1 Market size and forecast
5.5 Leukemia
5.5.1 Market size and forecast
5.6 Lung cancer
5.6.1 Market size and forecast
5.7 Melanoma
5.7.1 Market size and forecast
5.8 Prostate cancer
5.8.1 Market size and forecast
5.9 Others
5.9.1 Market size and forecast

Part 6. Global market for stem cell treatments for cancer by region
6.1 Asia Pacific
6.1.1 Market size and forecast
6.2 Europe
6.2.1 Market size and forecast
6.3 North America
6.3.1 Market size and forecast
6.4 Rest of the World (RoW)
6.4.1 Market size and forecast

Part 7. Key competitor profiles
7.1 apceth Biopharma GmbH
7.2 BioNTech SE
7.3 Celgene Corporation
7.4 ExCellThera Inc.
7.5 Fluxion Biosciences, Inc.
7.6 Gamida-Cell Ltd
7.7 ImmunoCellular Therapeutics, Ltd.
7.8 OncoCyte Corporation
7.9 OncoMed Pharmaceuticals, Inc.
7.10 Pluristem Therapeutics Inc.
7.11 SELLAS Life Sciences Group, Inc.
7.12 ViaCyte, Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

DISCLAIMER
ABOUT GEN CONSULTING COMPANY

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved